Search

Search bills, members, committees and pages...

Sign In

PRIME THERAPEUTICS

PreviousNext

45 federal lobbying filings, 2023 to 2026.

PRIME THERAPEUTICS is a client on 45 federal lobbying filings, 2023 to 2026, reporting $740K across them. Pharmacy solutions partner for health plans and employers. Based in Minnesota.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

4 it has hired, by filings.

RegistrantFilingsReported
GOVERNMENT COUNSEL, LLC15$440K
STUMPTOWN STRATEGIES15$300K
PRIME THERAPEUTICS14—
RED+BLUE STRATEGIES1—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20268$120K$220K
202512$200K$720K
202412$200K$390K
202313$220K$320K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues43
MMMMedicare/Medicaid23
PHAPharmacy15
TRDTrade (domestic/foreign)3
BUDBudget/Appropriations1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 2214DRUG Act12
S. 891Bipartisan Health Care Act8
H.R. 5378Tribal Healthcare Careers Act4
S. 2355Patients Deserve Price Tags Act4
S. 526Pharmacy Benefit Manager Transparency Act of 20254
H.R. 5526Biosimilar Red Tape Elimination Act3
H.R. 1An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.2
H.R. 1227Alternatives to PAIN Act2
H.R. 4317PBM Reform Act of 20252
H.R. 6703Lower Health Care Premiums for All Americans Act2
H.R. 7148Consolidated Appropriations Act, 20262
H.R. 8143Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.2
S. 1954Biosimilar Red Tape Elimination Act2
S. 3345PBM Price Transparency and Accountability Act2
S. 3822Break Up Big Medicine Act2
H.R. 4231Treat and Reduce Obesity Act of 20251
H.R. 5031Preserving Patient Access to Long-Term Care Pharmacies Act1
H.R. 9096Deport the Terrorists Act of 20261
H.R. 9393Lower Costs, More Transparency Act of 20261
S. 1339Stop CCP Money Laundering Act of 20251
S. 2305FRONT Act1
S. 3159Preserving Patient Access to Long-Term Care Pharmacies Act1
S. 832EPIC Act of 20251

Lobbyists

Named on the filings.

LobbyistClientsFilings
BLAIR LARKINS115
HENRY MENN114
JULIE CANTOR-WEINBERG114
ANNABELL STOKES11
BENJAMIN KLEIN11
DAVID ROOT11
KATHRYN WISE11
MEGAN MARSHALL11

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2026 third_quarter$20KAug 18, 2026
PRIME THERAPEUTICSRED+BLUE STRATEGIES2026 third_quarter—Aug 13, 2026
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2026 second_quarter$20KJul 20, 2026
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2026 second_quarter$30KJul 17, 2026
PRIME THERAPEUTICSPRIME THERAPEUTICS2026 second_quarter$100KJul 16, 2026
PRIME THERAPEUTICSPRIME THERAPEUTICS2026 first_quarter$120KApr 20, 2026
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2026 first_quarter$30KApr 20, 2026
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2026 first_quarter$20KApr 7, 2026
PRIME THERAPEUTICSPRIME THERAPEUTICS2025 fourth_quarter$100KJan 20, 2026
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2025 fourth_quarter$20KJan 19, 2026
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2025 fourth_quarter$30KJan 19, 2026
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2025 third_quarter$20KOct 20, 2025
PRIME THERAPEUTICSPRIME THERAPEUTICS2025 third_quarter$100KOct 16, 2025
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2025 third_quarter$30KOct 3, 2025
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2025 second_quarter$20KJul 21, 2025
PRIME THERAPEUTICSPRIME THERAPEUTICS2025 second_quarter$100KJul 16, 2025
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2025 second_quarter$30KJul 9, 2025
PRIME THERAPEUTICSPRIME THERAPEUTICS2025 first_quarter$420KApr 21, 2025
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2025 first_quarter$30KApr 15, 2025
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2025 first_quarter$20KApr 13, 2025
PRIME THERAPEUTICSPRIME THERAPEUTICS2024 fourth_quarter$100KJan 21, 2025
PRIME THERAPEUTICSSTUMPTOWN STRATEGIES2024 fourth_quarter$20KJan 21, 2025
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2024 fourth_quarter$30KJan 9, 2025
PRIME THERAPEUTICSGOVERNMENT COUNSEL, LLC2024 third_quarter$30KOct 18, 2024
PRIME THERAPEUTICSPRIME THERAPEUTICS2024 third_quarter$100KOct 17, 2024